TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetes Mellitus, Type 2Heart FailureCognitive Decline

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

Eligible age

18+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies

Sponsor: University Hospital, Lille

You may qualify if…

  • Adults
  • Persons able to understand and object to the information provided.
  • Type 2 diabetic patient free of heart failure ≥stade B
  • Patient affiliated with a social security scheme.
  • Patient agreeing to sign the informed consent form

You may not qualify if…

  • Patient with dementia
  • Patient with at least one of the criteria for heart failure ≥stade B

Source: ClinicalTrials.gov · NCT04583800 · last updated 2025-12-23

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes · TrialPath